4.7 Article

SARS-CoV-2 variants of concern partially escape humoral but not T- cell responses in COVID-19 convalescent donors and vaccinees

Journal

SCIENCE IMMUNOLOGY
Volume 6, Issue 59, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciimmunol.abj1750

Keywords

-

Categories

Funding

  1. Top Sector Life Sciences Health
  2. Health Holland [EMCLHS20017]
  3. European Union's Horizon 2020 research and innovation program [101003589]
  4. ZonMW [10150062010005, 10150062010008]
  5. Netherlands Organization for Scientific Research (NWO)
  6. Bill AMP
  7. Melinda Gates Foundation [INV-002022]
  8. Amsterdam UMC AMC Fellowship

Ask authors/readers for more resources

This study suggests that some variants might partially escape humoral immunity induced by SARS-CoV-2 infection or BNT162b2 vaccination, but the S-specific CD4(+) T-cell activation is not affected by the mutations in the B.1.1.7 and B.1.351 variants.
The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has raised concern about potential immune escape. Here, we studied humoral and cellular immune responses to wild type SARS-CoV-2 and the B.1.1.7 and B. 1.351 variants of concern in a cohort of 121 BNT162b2 mRNA-vaccinated health care workers (HCW). Twenty-three HCW recovered from mild COVID-19 disease and exhibited a recall response with high levels of SARS- CoV-2-specific functional antibodies and virus- specific T cells after a single vaccination. Specific immune responses were also detected in seronegative HCW after one vaccination, but a second dose was required to reach high levels of functional antibodies and cellular immune responses in all individuals. Vaccination- induced antibodies cross- neutralized the variants B. 1.1.7 and B. 1.351, but the neutralizing capacity and Fc-mediated functionality against B. 1.351 was consistently 2to 4-fold lower than to the homologous virus. In addition, peripheral blood mononuclear cells were stimulated with peptide pools spanning the mutated S regions of B. 1.1.7 and B.1.351 to detect crossreactivity of SARS-CoV-2-specific T cells with variants. Importantly, we observed no differences in CD4(+) Tcell activation in response to variant antigens, indicating that the B.1.1.7 and B.1.351 S proteins do not escape T-cell-mediated immunity elicited by the wild type S protein. In conclusion, this study shows that some variants can partially escape humoral immunity induced by SARS-CoV- 2 infection or BNT162b2 vaccination, but S-specific CD4(+) T-cell activation is not affected by the mutations in the B.1.1.7 and B.1.351 variants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available